Statistics for EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin
Total visits
| views | |
|---|---|
| EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin | 63 |
Total visits per month
| views | |
|---|---|
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
File Visits
| views | |
|---|---|
| Eur Urol 2016 60.pdf(legacy) | 714 |
| Eur Urol 2016 60.pdf | 33 |
Top country views
| views | |
|---|---|
| Germany | 26 |
| United States | 20 |
| China | 8 |
| Canada | 3 |
| France | 1 |
| Greece | 1 |
| Italy | 1 |
| Portugal | 1 |
| Turkey | 1 |
| Ukraine | 1 |